PDF(Pubmed)
Abstract：
BACKGROUND: With high increase in myopia prevalence, we aimed to assess whether Plusoptix_A09 can be used in myopic children over spectacles to predict visual acuity (VA) and myopic refraction changes.
METHODS: Myopic children underwent a complete ophthalmological examination. Plusoptix_A09 was performed over spectacles. VA changes, refraction changes and time since previous glasses prescription, were determined. Age, current or past history of amblyopia, presence of strabismus and self-perception of VA changes were registered.
RESULTS: In total, 199 patients were included. Spherical power (SP) and spherical equivalent (SE) measured by Plusoptix_A09 over spectacles predicted both VA changes (p < 0.001) and refraction changes (p < 0.001). Values of SP < - 0.06D or SE < - 0.22D indicated a VA decrease (AUC > 0.9, p < 0.01) for sensitivity and specificity of 85.1%, 82.1% and 82.6%, 83.3%, respectively. Age and ophthalmological comorbidities did not influence Plusoptix_A09 measurements (p > 0.05). Plusoptix_A09 over spectacles was a stronger predictor of VA changes when compared to children\'s self-perception, either in 4-9-year-old patients (p < 0.001 versus p = 0.628) and in 10-18-year-old children (OR < = 0.066 versus OR = 0.190). A decrease in SP and SE of - 0.10D in Plusoptix_A09 predicted a myopia progression of - 0.04D and - 0.05D, respectively.
CONCLUSIONS: This study unveiled new features for the Plusoptix, a worldwide available photoscreener used in amblyopia screening. When Plusoptix is performed in children with their glasses on, it can rapidly predict myopia progression. For each decrease of - 0.10D in Plusoptix, a myopia progression of -0.05D is expected. Moreover, Plusoptix is more reliable than children\'s self-perception of visual acuity changes, making it a useful tool either in primary care or ophthalmology practice.
METHODS: Myopic children underwent a complete ophthalmological examination. Plusoptix_A09 was performed over spectacles. VA changes, refraction changes and time since previous glasses prescription, were determined. Age, current or past history of amblyopia, presence of strabismus and self-perception of VA changes were registered.
RESULTS: In total, 199 patients were included. Spherical power (SP) and spherical equivalent (SE) measured by Plusoptix_A09 over spectacles predicted both VA changes (p < 0.001) and refraction changes (p < 0.001). Values of SP < - 0.06D or SE < - 0.22D indicated a VA decrease (AUC > 0.9, p < 0.01) for sensitivity and specificity of 85.1%, 82.1% and 82.6%, 83.3%, respectively. Age and ophthalmological comorbidities did not influence Plusoptix_A09 measurements (p > 0.05). Plusoptix_A09 over spectacles was a stronger predictor of VA changes when compared to children\'s self-perception, either in 4-9-year-old patients (p < 0.001 versus p = 0.628) and in 10-18-year-old children (OR < = 0.066 versus OR = 0.190). A decrease in SP and SE of - 0.10D in Plusoptix_A09 predicted a myopia progression of - 0.04D and - 0.05D, respectively.
CONCLUSIONS: This study unveiled new features for the Plusoptix, a worldwide available photoscreener used in amblyopia screening. When Plusoptix is performed in children with their glasses on, it can rapidly predict myopia progression. For each decrease of - 0.10D in Plusoptix, a myopia progression of -0.05D is expected. Moreover, Plusoptix is more reliable than children\'s self-perception of visual acuity changes, making it a useful tool either in primary care or ophthalmology practice.
摘要：
背景：随着近视患病率的升高，我们的目的是评估Plusoptix_A09是否可用于近视儿童戴眼镜来预测视力(VA)和近视屈光变化.
方法：近视儿童接受完整的眼科检查。Plusoptix_A09在眼镜上进行。VA变化，屈光变化和自以前的眼镜处方的时间，决心。年龄,现在或过去的弱视史，记录了斜视的存在和对VA变化的自我感知。
结果：总计，199名患者被纳入。通过Plusoptix_A09在眼镜上测量的球面屈光力（SP）和球面当量（SE）预测了VA变化（p<0.001）和屈光变化（p<0.001）。SP值<-0.06D或SE<-0.22D表明VA降低（AUC>0.9，p<0.01），敏感性和特异性为85.1％，82.1%和82.6%，83.3%,分别。年龄和眼科合并症不影响Plusoptix_A09测量值(p>0.05)。与儿童的自我感知相比，眼镜上的Plusoptix_A09是VA变化的更强预测因子，在4-9岁患者（p<0.001对p=0.628）和10-18岁儿童中（OR<=0.066对OR=0.190）。Plusoptix_A09中SP和SE下降-0.10D预测近视进展-0.04D和-0.05D，分别。
结论：这项研究揭示了Plusoptix的新功能，用于弱视筛查的世界范围内可用的光筛选器。当Plusoptix在戴眼镜的儿童中进行时，它可以快速预测近视进展。对于Plusoptix每减少-0.10D，预计近视进展为-0.05D。此外，Plusoptix比儿童对视力变化的自我感知更可靠，使其成为初级保健或眼科实践中的有用工具。
方法：近视儿童接受完整的眼科检查。Plusoptix_A09在眼镜上进行。VA变化，屈光变化和自以前的眼镜处方的时间，决心。年龄,现在或过去的弱视史，记录了斜视的存在和对VA变化的自我感知。
结果：总计，199名患者被纳入。通过Plusoptix_A09在眼镜上测量的球面屈光力（SP）和球面当量（SE）预测了VA变化（p<0.001）和屈光变化（p<0.001）。SP值<-0.06D或SE<-0.22D表明VA降低（AUC>0.9，p<0.01），敏感性和特异性为85.1％，82.1%和82.6%，83.3%,分别。年龄和眼科合并症不影响Plusoptix_A09测量值(p>0.05)。与儿童的自我感知相比，眼镜上的Plusoptix_A09是VA变化的更强预测因子，在4-9岁患者（p<0.001对p=0.628）和10-18岁儿童中（OR<=0.066对OR=0.190）。Plusoptix_A09中SP和SE下降-0.10D预测近视进展-0.04D和-0.05D，分别。
结论：这项研究揭示了Plusoptix的新功能，用于弱视筛查的世界范围内可用的光筛选器。当Plusoptix在戴眼镜的儿童中进行时，它可以快速预测近视进展。对于Plusoptix每减少-0.10D，预计近视进展为-0.05D。此外，Plusoptix比儿童对视力变化的自我感知更可靠，使其成为初级保健或眼科实践中的有用工具。
